抗辐射药物市场：依适应症、给药途径、配销通路及地区划分

预计2023年全球抗辐射药物市场规模为5.874亿美元，2030年预计将达9.31亿美元，2023年至2030年复合年增长率为6.8%。

图 1. 2023 年按地区分類的抗辐射药物全球市场占有率(%)

抗辐射药物是用来对抗辐射暴露对人体产生的负面影响的药物。近年来，抗辐射药物的需求不断增加，因为长期暴露于电离辐射会对身体产生有害影响，导致放射病、癌症、基因突变等各种健康问题。

这些药物的作用是保护人体细胞和 DNA 免受辐射的有害影响。抗辐射剂可降低辐射引起的疾病的风险并提高辐射暴露个体的生存率。抗辐射剂可用作在涉及辐射暴露的行业工作的人员以及生活在易受自然辐射的地区的人员的预防措施。

市场动态：

预计全球抗辐射药物市场在不久的将来将出现显着成长。癌症盛行率的增加以及癌症治疗中放射线治疗的日益采用推动了市场的成长。核能发电厂的增加以及潜在的辐射洩漏风险将进一步推动抗辐射药物的需求。

也存在一些限制市场成长的因素。其中包括抗辐射药物的高成本以及药物审批的严格监管要求。此外，医疗保健专业人员和一般民众对抗辐射剂的可用性和益处缺乏认识也可能阻碍市场成长。

儘管面临挑战，但市场仍存在许多成长机会。人们对研发活动的投资不断增加，以开发新的和改进的抗辐射药物，预计将在市场上创造机会。对个人化医疗的需求不断增长以及对精准医疗的日益关注预计将推动市场成长。

本研究的主要特点

• 本报告对全球抗辐射药物市场进行了详细分析，包括以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
• 它还揭示了各个细分市场的潜在商机，并说明了有吸引力的投资提案。
• 它提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 根据公司亮点、产品系列、财务实绩和策略等参数，对全球抗辐射药物市场的主要企业进行了分析。
• 本报告中包含的知名公司包括 Amgen Inc.、Partner Therapeutics Inc.、RedHill Biopharma Ltd.、Humanetics Corporation、RxBio Inc.、Soligenix Inc.、Aeolus Pharmaceuticals、Onconova Therapeutics、Genome Protection Inc.。
• 该报告的见解使行销人员和负责人能够就产品发布、升级、市场扩张和行销策略做出资讯的决策。
• 本报告针对产业内的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以从用于分析全球抗辐射药物市场的各种策略矩阵中受益，以促进决策。

目录

第一章 研究目的与假设

• 研究目标
• 假设
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 全球癌症发生率增加
• 核能事故的增加和核电事故的威胁
• 有利于药物开发的法规环境
• 药物输送系统的技术进步
  • 抑制因素
  • 机会
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章全球抗辐射药物市场 -冠状病毒（COVID-19）大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章2018-2030年全球抗辐射药物市场（按适应症）

• 介绍
• 急性辐射症候群
• 延迟辐射综合症

第六章 全球抗辐射药物市场，依给药途径，2023-2030

• 介绍
• 口服
• 肌肉注射

第七章全球抗辐射药物市场，依配销通路，2018-2030

• 介绍
• 医院药房
• 零售药房
• 其他的

第八章2018-2030年全球抗辐射药物市场（按地区）

• 介绍
• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 东南亚国协
• 澳洲
• 韩国
• 其他亚太地区
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章竞争形势

• Amgen Inc.
• Partner Therapeutics Inc.
• RedHill Biopharma Ltd.
• Humanetics Corporation
• RxBio Inc.
• Soligenix Inc.
• Aeolus Pharmaceuticals
• Onconova Therapeutics
• Genome Protection Inc.

第10章

• 调查方法
• 关于出版商

Global Anti-Radiation Drugs Market size is expected to be valued at US$ 587.4 Mn in 2023, and is expected to reach US$ 931 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030.

Figure 1. Global Anti-Radiation Drugs Market Share (%), By Region, 2023

Anti-radiation drugs are pharmaceutical medications that are used to combat the harmful effects of radiation exposure in humans. Prolonged exposure to ionizing radiation can have detrimental effects on the body that leads to various health issues such as radiation sickness, cancer, and genetic mutations, and this has boosted demand for anti-radiation drugs in recent years.

These drugs work by protecting the body's cells and DNA from the damaging effects of radiation. These aid in reducing the risk of radiation-induced illnesses and improving the chances of survival for individuals exposed to radiation. Anti-radiation drugs can be used as preventive measures for people working in industries that involve radiation exposure, as well as for individuals in areas prone to natural radiation.

Market Dynamics:

Global anti-radiation drugs market is projected to witness significant growth in the near future. The market growth is driven by increasing prevalence of cancer and growing adoption of radiation therapy in cancer treatment. Rising number of nuclear power plants, along with the potential risk of radiation leaks, further boosts demand for anti-radiation drugs.

There are certain factors that may restrain the market growth. These include the high cost of anti-radiation drugs and the stringent regulatory requirements for drug approval. Moreover, the lack of awareness about the availability and benefits of these drugs among healthcare professionals and the general population could hinder market growth.

Despite the challenges, the market presents numerous opportunities for growth. Increasing investment in research and development activities to develop new and improved anti-radiation drugs expected to offer opportunity to the market. Rising demand for personalized medicine and growing focus on precision healthcare are expected to drive the market growth.

Key Features of the Study:

• This report provides in-depth analysis of the global anti-radiation drugs market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
• It elucidates potential revenue opportunities across different market segments and explains attractive investment propositions
• The study provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and the competitive strategies adopted by key players
• Key players in the global anti-radiation drugs market are profiled based on parameters such as company highlights, product portfolio, financial performance, and strategies
• The report includes prominent companies such as Amgen Inc., Partner Therapeutics Inc., RedHill Biopharma Ltd., Humanetics Corporation, RxBio Inc., Soligenix Inc., Aeolus Pharmaceuticals, Onconova Therapeutics, and Genome Protection Inc.
• Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
• The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders can benefit from the various strategy matrices used in analyzing the global anti-radiation drugs market, facilitating ease in decision-making

Anti-Radiation Drugs Market Detailed Segmentation:

• By Indication
  • Acute Radiation Syndrome
  • Delayed Radiation Syndrome
• By Route of Administration
  • Oral
  • Intramuscular
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Amgen Inc.
  • Partner Therapeutics Inc.
  • RedHill Biopharma Ltd.
  • Humanetics Corporation
  • RxBio Inc.
  • Soligenix Inc.
  • Aeolus Pharmaceuticals
  • Onconova Therapeutics
  • Genome Protection Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Indication
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing incidence of cancer globally
• Growing threat of nuclear accidents and events
• Favorable regulatory environment for drug development
• Technological advancements in drug delivery systems
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Anti-Radiation Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Anti-Radiation Drugs Market, By Indication, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Acute Radiation Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Delayed Radiation Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Anti-Radiation Drugs Market, By Route of Administration, 2023-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018- 2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Anti-Radiation Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Anti-Radiation Drugs Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Amgen Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Partner Therapeutics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RedHill Biopharma Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Humanetics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RxBio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Soligenix Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Aeolus Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Onconova Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genome Protection Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us